Pricing and Reimbursement is one of the most plastic fields in finance with European countries all having different policies on
pricing and reimbursement with pros and cons to each system.
We will be hosting our prestigious
Pharmaceutical Pricing and Reimbursement conference. It will be held on the 5th to the 6th October 2015 at the Holiday InnHotel Regents Park, London. The conference is one of the most established in the world having run for 21 years highlighting the changes in the field over this period of time.
Our experts will provide advice on current changes and highlight methods to deal with changes through case study examples and discussion. This year’s agenda will have a strong focus on international changes in policy along with an in-depth section on biosimilar dugs and the impact they have had on
Pricing and Reimbursement through different nations in Europe.
Key topics include:
- New models for cancer drug funding
- Developing new market access models for orphan drugs
- Changes in the PPRS scheme post election
- Tiered pricing
- AMNOG process and the role of IQWiG
Benefits of Attending
- Gain key insights into the field of biosimilar drugs
- The impact of biosimilar in the field of pricing and reimbursement
- Learn about new policies
- Gain invaluable information from field leaders through in depth case studies
- Gain a strong understanding of current and potential changes in HTA
- Developing co-creation relations with payers and stakeholders.
- Using new Payment models
- Health reforms and harmonisation in Europe
Plus One Interactive Half-Day Post-Conference Workshop | Wednesday 7th October 2015
HTA UncoveredWorkshop leaders: Anke Van Engen, Principal, Advisory Services, Quintiles
Janice Haigh, Practice Leader Market Access, Quintiles
8.30am - 12.30pm
Speakers
- Alexander Roediger, Director European Union Affairs, MSD
- Alexander Natz, Secretary General, EUCOPE – European Confederation of Pharmaceutical Entrepreneurs
- Annalisa Belloni, Health Policy Analyst, Organisation For Economic Co-Operation & Development (O E C D)
- Cord Willhoft, Partner, Field Fisher
- David Watson, Director of Pricing & Reimbursement, Association of the British Pharmaceutical Industry (ABPI)
- Donald Macarthur, Global Pharmaceutical Business Analyst, DM pharma issues
- Eric Low, CEO, Myeloma UK
- Fabrizio Gianfrate, Professor of Health Economics, University of Rome
- Janice Haigh, Practice Leader, Market Access, Quintiles (UK) Ltd
- Ken Walsh, Head of Emerging Markets Pricing, GSK
- Leslie Galloway, Chairman, Ethical Medicines Industry Group
- Leyla Hannbeck, Head of Pharmacy, National Pharmaceutical Association Ltd
- Maggie Dolan, Specialist Procurement Pharmacist, NHS Commercial Solutions
- Matthias Heck, Attorney-at-law, Head of Brussels office, German Pharmaceutical Industry Association
- Nick Bosanquet, Professor of Health Policy, Imperial College London
- Peter Hertzman, CEO, Health Access Agency
- Stefan Walzer, General Manager (MArS) – Tutor, MArS Market Access & Pricing Strategy GmbH and State University Baden-Wuerttemberg
- Steve Williamson, Consultant Cancer Pharmacist, Northumbria NHS Trusts / NHS England
- Toros Sahin, Head of Market Access & Health Economics, Sanofi-Turkey
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloada at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Venue
Holiday Inn Regents ParkCarburton Street
London
W1W 5EE England
